Skip to main content
. 2015 Jun 4;5:10893. doi: 10.1038/srep10893

Figure 8. HDAB is a potential inhibitor of PARP-1 and PARP-2.

Figure 8

(A, B) Computational modelling of HDAB binding to PARP-1 and PARP-2. (C) The inhibitory effect of HDAB on PARP-1 activity was measured using a PARP Assay Kit. The data from three independent experiments are expressed as relative inhibition rates; the inhibition rate in the control was set to 0. (D) Clonogenic survival assays of HDAB for MCF-7 and MDA-MB-436 human breast cancer cells. (E) Clonogenic survival assays of 3-AB for MCF-7 and MDA-MB-436 human breast cancer cells. Three independent experiments were performed and the data are presented as the mean ±SD. The colony formation of non-treated cells was set to 100.